Breast cancer risk from menopause hormones may last decades

by Marilynn MarchioneIn this May 6, 2010 file photo, a radiologist checks mammograms in in Los Angeles. Women who use certain types of hormones after menopause still have an increased risk of developi

Updated on: December 22,2023

Breast cancer risk from menopause hormones may last decades

by Marilynn MarchioneIn this May 6, 2010 file photo, a radiologist checks mammograms in in Los Angeles. Women who use certain types of hormones after menopause still have an increased risk of developi

Updated on:December 22,2023

Patient error makes 1 in 10 home colon cancer tests unusable

by Dennis ThompsonAt-home tests for colon cancer make this important screening readily available to folks who can't afford or would rather not go through a colonoscopy.Unfortunately, more than 1 i

Updated on: December 26,2023

Patient error makes 1 in 10 home colon cancer tests unusable

by Dennis ThompsonAt-home tests for colon cancer make this important screening readily available to folks who can't afford or would rather not go through a colonoscopy.Unfortunately, more than 1 i

Updated on:December 26,2023

A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

by Bob Yirka , Medical XpressSchematic of the experimental design. (A) Schematic design of the TDP study of metastatic (SW620) and nonmetastatic (SW480) CRC cells using CZE-ESI-MS/MS and LC-CZE-ESI-MS

Updated on: December 20,2023

A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

by Bob Yirka , Medical XpressSchematic of the experimental design. (A) Schematic design of the TDP study of metastatic (SW620) and nonmetastatic (SW480) CRC cells using CZE-ESI-MS/MS and LC-CZE-ESI-MS

Updated on:December 20,2023

Free tool simplifies cancer research

byKarolinska InstitutetCredit: CC0 Public DomainEvery cell contains a vast number of proteins, each of which has a specific function, for example, as a receptor for another molecule or an enzyme

Updated on: December 22,2023

Free tool simplifies cancer research

byKarolinska InstitutetCredit: CC0 Public DomainEvery cell contains a vast number of proteins, each of which has a specific function, for example, as a receptor for another molecule or an enzyme

Updated on:December 22,2023

Combining cholesterol-lowering statins with existing cancer drug shows potent effect against breast cancer subtype

by Katie Brace,Beth Israel Deaconess Medical CenterTN/ER-low PDOs are sensitive to combination AZD5363 and pitavastatin. A panel of breast cancer PDOs were treated with DMSO, 1 µM AZD5363, 5 µM

Updated on: August 26,2024

Combining cholesterol-lowering statins with existing cancer drug shows potent effect against breast cancer subtype

by Katie Brace,Beth Israel Deaconess Medical CenterTN/ER-low PDOs are sensitive to combination AZD5363 and pitavastatin. A panel of breast cancer PDOs were treated with DMSO, 1 µM AZD5363, 5 µM

Updated on:August 26,2024

Scientists identify link between mitochondria and pancreatic cancer risk

byThe Wistar InstituteDifferential expression of a Mic60-low gene signature in cancer. Credit:PLOS ONE(2022). DOI: 10.1371/journal.pone.0273520The mitochondria is a key energy-produc

Updated on: December 27,2023

Scientists identify link between mitochondria and pancreatic cancer risk

byThe Wistar InstituteDifferential expression of a Mic60-low gene signature in cancer. Credit:PLOS ONE(2022). DOI: 10.1371/journal.pone.0273520The mitochondria is a key energy-produc

Updated on:December 27,2023

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on: March 30,2024

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on:March 30,2024

Disruption of immune cells in blood is linked to cancer outcomes, new tool reveals

Updated on: April 29,2025

Disruption of immune cells in blood is linked to cancer outcomes, new tool reveals

Updated on:April 29,2025

Colon cancer: Dying cancer cells give neighboring tumor cells instructions on how to survive

by Markus Bernards,Goethe University Frankfurt am MainDying tumor cells induce mTOR survival signaling in a paracrine manner. Credit:Nature(2022). DOI: 10.1038/s41586-022-05426-1Colo

Updated on: December 26,2023

Colon cancer: Dying cancer cells give neighboring tumor cells instructions on how to survive

by Markus Bernards,Goethe University Frankfurt am MainDying tumor cells induce mTOR survival signaling in a paracrine manner. Credit:Nature(2022). DOI: 10.1038/s41586-022-05426-1Colo

Updated on:December 26,2023

Research identifies new route for tackling drug resistance in skin cancer cells

byQueen Mary, University of LondonA drug-resistant melanoma cell that has altered its cytoskeleton. Credit: Queen Mary University of LondonResearchers have found that melanoma cells fight anti-c

Updated on: December 20,2023

Research identifies new route for tackling drug resistance in skin cancer cells

byQueen Mary, University of LondonA drug-resistant melanoma cell that has altered its cytoskeleton. Credit: Queen Mary University of LondonResearchers have found that melanoma cells fight anti-c

Updated on:December 20,2023

Finding community online after finding a lump: Social media and younger adults with cancer

by Jaigris Hodson and Cheryl Heykoop,The ConversationCredit: AI-generated imageOctober marks Breast Cancer Awareness Month. The Canadian Cancer Society estimates thatone in eight women wil

Updated on: December 22,2023

Finding community online after finding a lump: Social media and younger adults with cancer

by Jaigris Hodson and Cheryl Heykoop,The ConversationCredit: AI-generated imageOctober marks Breast Cancer Awareness Month. The Canadian Cancer Society estimates thatone in eight women wil

Updated on:December 22,2023

Study suggests the possibility of combination therapy of SORA and FGF21 in hepatocellular carcinoma

by Higher Education PressFGF21 combined with SORA promotes apoptosis and inhibits proliferation of 7721‐Smad3 cells under anaerobic conditions. Credit: Ting Zhang, Huiling Shi, Shihui Zhang, Qin Zhu,

Updated on: May 16,2024

Study suggests the possibility of combination therapy of SORA and FGF21 in hepatocellular carcinoma

by Higher Education PressFGF21 combined with SORA promotes apoptosis and inhibits proliferation of 7721‐Smad3 cells under anaerobic conditions. Credit: Ting Zhang, Huiling Shi, Shihui Zhang, Qin Zhu,

Updated on:May 16,2024